Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12569439 | Bottom-up assembly of synthetic extracellular vesicles | 🖼🧊📄§ | 2026-03-10 | 2041-01-29 | 0 | 31 |
| 12569467 | Small molecules that treat or prevent viral infections | 🖼🧊📄§ | 2026-03-10 | 2043-02-17 | 0 | 31 |
| 12569523 | Engineered therapeutic probiotic system and method | 🖼🧊📄§ | 2026-03-10 | 2044-02-04 | 0 | 31 |
| 12569551 | Modified immunogenic proteins | 🖼🧊📄§ | 2026-03-10 | 2042-10-24 | 0 | 31 |
| 12569577 | PSMA-targeting imaging agents | 🖼🧊📄§ | 2026-03-10 | 2040-10-28 | 0 | 31 |
| 12569559 | Engineered dendritic cell and use thereof | 🖼🧊📄§ | 2026-03-10 | 2045-01-18 | 0 | 31 |
| 12569540 | Human recombinant hyposialylated erythropoietin, methods of purification and therapeutic uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-02-19 | 0 | 31 |
| 12569566 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | 🖼🧊📄§ | 2026-03-10 | 2040-02-12 | 0 | 31 |
| 12571014 | Low glycemic sugar composition | 🖼🧊📄§ | 2026-03-10 | 2044-01-25 | 0 | 31 |
| 12570752 | Combination therapy with an anti BCMA antibody and a gamma secretase inhibitor | 🖼🧊📄§ | 2026-03-10 | 2040-04-09 | 0 | 31 |
| 12569498 | Methods and compositions for the prevention and treatment of ischemia reperfusion injury and infection | 🖼🧊📄§ | 2026-03-10 | 2040-11-06 | 0 | 31 |
| 12569700 | Methods of use of ultra-high dose rate radiation and therapeutic agent | 🖼🧊📄§ | 2026-03-10 | 2043-08-24 | 0 | 31 |
| 12571020 | Genetically engineered microorganisms that overexpress microcin-mge and methods of purification and use | 🖼🧊📄§ | 2026-03-10 | 2041-02-23 | 0 | 31 |
| 12570748 | Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof | 🖼🧊📄§ | 2026-03-10 | 2044-06-13 | 0 | 31 |
| 12570974 | Oligonucleotides for controlling tau splicing, and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2039-07-03 | 0 | 31 |
| 12570982 | Altering gene expression in modified T cells and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2041-12-14 | 0 | 31 |
| 12570959 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-03-10 | 2042-08-30 | 0 | 31 |
| 12570963 | Gene therapies for lysosomal disorders | 🖼🧊📄§ | 2026-03-10 | 2043-04-11 | 0 | 31 |
| 12569548 | RNA construct | 🖼🧊📄§ | 2026-03-10 | 2040-06-18 | 0 | 31 |
| 12570634 | Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2043-06-26 | 0 | 31 |
| 12570767 | Sequences of anti-ecto-5′-nucleotidase antibodies | 🖼🧊📄§ | 2026-03-10 | 2042-05-27 | 0 | 31 |
| 12570597 | Polyaryl carboxylic fullerene derivative and use thereof in anti-coronavirus infection | 🖼🧊📄§ | 2026-03-10 | 2041-08-09 | 0 | 31 |
| 12569470 | Vasodilator and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-12-18 | 0 | 31 |
| 12569515 | Gold-containing agents for the treatment of lung infections | 🖼🧊📄§ | 2026-03-10 | 2041-03-15 | 0 | 31 |
| 12569534 | Therapeutic nanoparticles by coacervate complexation and their use for treating bacteria | 🖼🧊📄§ | 2026-03-10 | 2039-07-30 | 0 | 31 |
| 12569454 | Nucleophilic chemicals useful in the treatment of cisplatin-induced sensory neuropathy and ototoxicity | 🖼🧊📄§ | 2026-03-10 | 2039-12-27 | 0 | 31 |
| 12569452 | Ophthalmic compositions comprising F6H8 | 🖼🧊📄§ | 2026-03-10 | 2044-02-12 | 0 | 31 |
| 12569430 | Biodegradable implant including naltrexone | 🖼🧊📄§ | 2026-03-10 | 2042-04-01 | 0 | 31 |
| 12569495 | Inhibitors of porcine reproductive and respiratory syndrome virus | 🖼🧊📄§ | 2026-03-10 | 2041-05-28 | 0 | 31 |
| 12569493 | Treatment of chemosensory dysfunction from a coronavirus infection | 🖼🧊📄§ | 2026-03-10 | 2041-03-19 | 0 | 31 |
| 12569512 | Heparan sulfate (HS) oligosaccharides effect in liver ischemia reperfusion injury | 🖼🧊📄§ | 2026-03-10 | 2042-05-13 | 0 | 31 |
| 12570980 | Methods and compositions for treating inflammatory conditions associated with infectious disease | 🖼🧊📄§ | 2026-03-10 | 2045-04-02 | 0 | 31 |
| 12569482 | Methods and compositions for treating idiopathic pulmonary fibrosis | 🖼🧊📄§ | 2026-03-10 | 2040-10-02 | 0 | 31 |
| 12569524 | Compositions and methods for preventing and treating antibiotic induced pathologies using probiotics in the biofilm state | 🖼🧊📄§ | 2026-03-10 | 2039-10-21 | 0 | 31 |
| 12569484 | Use of phosphodiesterase 5 inhibitor in preparation of medicament for resisting fibrotic diseases | 🖼🧊📄§ | 2026-03-10 | 2040-07-29 | 0 | 31 |
| 12571027 | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF | 🖼🧊📄§ | 2026-03-10 | 2044-09-10 | 0 | 31 |
| 12569491 | Methods for treating testicular and ovarian adrenal rest tumors | 🖼🧊📄§ | 2026-03-10 | 2045-01-31 | 0 | 31 |
| 12569325 | Device for use with body tissue sphincters | 🖼🧊📄§ | 2026-03-10 | 2043-03-20 | 0 | 31 |
| 12571796 | Viral exposure signature for detection of early stage hepatocellular carcinoma | 🖼🧊📄§ | 2026-03-10 | 2040-10-09 | 0 | 31 |
| 12569543 | Semaglutide in cardiovascular conditions | 🖼🧊📄§ | 2026-03-10 | 2037-04-28 | 0 | 31 |
| 12569556 | Aluminum based adjuvants for tolerogenic vaccination | 🖼🧊📄§ | 2026-03-10 | 2041-01-29 | 0 | 31 |
| 12570670 | Compounds, compositions, and methods for treating fibrosis | 🖼🧊📄§ | 2026-03-10 | 2040-01-30 | 0 | 31 |
| 12570639 | Tetrahydroquinoline derivative and medicinal use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-12-24 | 0 | 31 |
| 12570648 | 6,7-dihydro-5H-pyrido[2,3-c]pyridazine derivatives and related compounds as Bcl-xL protein inhibitors and pro-apoptotic agents for treating cancer | 🖼🧊📄§ | 2026-03-10 | 2040-07-28 | 0 | 31 |
| 12570686 | Chemical structures that control metabolic elimination of aminosterols | 🖼🧊📄§ | 2026-03-10 | 2045-02-18 | 0 | 31 |
| 12570728 | Combinations of antibodies and bispecific antibodies comprising antigen-binding specifically recognizing Pseudomonas PcrV and Psl | 🖼🧊📄§ | 2026-03-10 | 2041-11-18 | 0 | 31 |
| 12570679 | STAT3 protein degraders | 🖼🧊📄§ | 2026-03-10 | 2040-03-27 | 0 | 31 |
| 12570733 | Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules | 🖼🧊📄§ | 2026-03-10 | 2042-06-30 | 0 | 31 |
| 12570746 | Anti-PD-L1 antibodies | 🖼🧊📄§ | 2026-03-10 | 2040-09-24 | 0 | 31 |
| 12570675 | Boronic acid compounds | 🖼🧊📄§ | 2026-03-10 | 2041-12-10 | 0 | 31 |